Antonín Pavelka

Antonín Pavelka

Auto-generated profile, based on publicly available information

Antonín Pavelka

Infectious diseases and preventive medicine, Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2026 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
APAntonín Pavelka
Antonín Pavelka
BLBřEtislav Lipový
BřEtislav Lipový
LJLubomír Janda
Lubomír Janda
JBJana Brtníková
Jana Brtníková
MKMartin Knoz
Martin Knoz
LVLukáš Vacek
Lukáš Vacek
Given the global rise in antibiotic resistance, this study focuses on developing an alternative treatment for deep skin and soft tissue infections (SSTIs) caused by a carbapenem-resistant Pseudomonas aeruginosa. An injectable hydrogel composed of polyvinyl alcohol and chitosan was developed as a stable carrier for the porcine cathelicidins PR-39 and Protegrin-1. In vitro tests demonstrated that the addition of 8 mM EDTA fully restores the activity of antibacterial peptides in fetal bovine serum and eliminates the influence of divalent cations. In a porcine model, the application of this hydrogel resulted in a significant reduction in bacterial load after only two doses, with levels dropping below 105 CFU/g of tissue. In addition to eliminating the infection, the treated group showed early granulation tissue formation, reduced necrosis and inflammation, and the development of a continuous epidermis, all of which were completely absent in the untreated group. The research confirms that the combination of cathelicidins and EDTA in a hydrogel carrier represents a highly effective approach for treating complicated bacterial infections.